Engineered Cas12a enzymes in biosensing: From molecular mechanisms to clinical translation
Applied Materials Today · 2026-12 · 53 · 103429
DOI: 10.1016/j.apmt.2026.103429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Materials Today, 2026-12. Verfasst von Snehlata Kujur und 1 weiteren Autor:innen. Die Arbeit nennt 171 Literaturangaben.
Abstract (Originalsprache)
The CRISPR-Cas12a system is an excellent platform for next-generation molecular diagnostics due to its ability to recognize targets programmatically and collateral trans-cleavage activity, thus facilitating rapid and precise detection of nucleic acids. This review focuses on the molecular mechanism, structure, PAM recognition, R-loop formation, and RuvC activation of Cas12a, as well as on different orthologs and engineered variants that exhibit diverse activities, specificities, and PAM compatibilities. Recent advances in crRNA engineering, including spacer optimization, split crRNAs, and chemically modified guide RNAs, are also highlighted in this review. Furthermore, the evolution of Cas12a diagnostic platforms from DETECTR to advanced systems integrating microfluidic, electrochemical, Graphene field-effect transistor (GFET) technology, wearable sensors, and smartphones is discussed. Applications in infectious diseases, oncology, agriculture, environmental monitoring, and food safety demonstrate the broad translational potential of Cas12a biosensing technologies. Current platforms have achieved attomolar-to-femtomolar analytical sensitivity, rapid detection within minutes, and single-nucleotide discrimination under optimized assay conditions. Finally, major challenges, including multiplexing scalability, quantitative accuracy, enzyme stability, and clinical standardization, are critically discussed alongside future directions involving AI-assisted guide design, digital CRISPR, and integrated point-of-care systems. Collectively, Cas12a-based biosensing represents a versatile, scalable framework for precision diagnostics and next-generation, decentralized healthcare technologies.
Zitieren
APA
Kujur, S., & Prasad, D. (2026). Engineered Cas12a enzymes in biosensing: From molecular mechanisms to clinical translation. Applied Materials Today, 53, 103429. https://doi.org/10.1016/j.apmt.2026.103429
Vancouver
Kujur S, Prasad D. Engineered Cas12a enzymes in biosensing: From molecular mechanisms to clinical translation. Applied Materials Today. 2026;53:103429. doi:10.1016/j.apmt.2026.103429
BibTeX
@article{Kujur2026,
author = {Kujur, Snehlata and Prasad, Dinesh},
title = {Engineered Cas12a enzymes in biosensing: From molecular mechanisms to clinical translation},
journal = {Applied Materials Today},
year = {2026},
volume = {53},
pages = {103429},
doi = {10.1016/j.apmt.2026.103429}
}
EUVIMED